An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations
Open Access
- 19 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0155811
Abstract
Drug development is both increasing in cost whilst decreasing in productivity. There is a general acceptance that the current paradigm of R&D needs to change. One alternative approach is drug repositioning. With target-based approaches utilised heavily in the field of drug discovery, it becomes increasingly necessary to have a systematic method to rank gene-disease associations. Although methods already exist to collect, integrate and score these associations, they are often not a reliable reflection of expert knowledge. Furthermore, the amount of data available in all areas covered by bioinformatics is increasing dramatically year on year. It thus makes sense to move away from more generalised hypothesis driven approaches to research to one that allows data to generate their own hypothesis. We introduce an integrated, data driven approach to drug repositioning. We first apply a Bayesian statistics approach to rank 309,885 gene-disease associations using existing knowledge. Ranked associations are then integrated with other biological data to produce a semantically-rich drug discovery network. Using this network, we show how our approach identifies diseases of the central nervous system (CNS) to be an area of interest. CNS disorders are identified due to the low numbers of such disorders that currently have marketed treatments, in comparison to other therapeutic areas. We then systematically mine our network for semantic subgraphs that allow us to infer drug-disease relations that are not captured in the network. We identify and rank 275,934 drug-disease has_indication associations after filtering those that are more likely to be side effects, whilst commenting on the top ranked associations in more detail. The dataset has been created in Neo4j and is available for download at https://bitbucket.org/ncl-intbio/genediseaserepositioning along with a Java implementation of the searching algorithm.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (1592752)
- GlaxoSmithKline foundation
This publication has 55 references indexed in Scilit:
- PhenoDigm: analyzing curated annotations to associate animal models with human diseasesDatabase: The Journal of Biological Databases and Curation, 2013
- Bayesian integration of networks without gold standardsBioinformatics, 2012
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Constructing a semantic predication gold standard from the biomedical literatureBMC Bioinformatics, 2011
- PREDICT: a method for inferring novel drug indications with application to personalized medicineMolecular Systems Biology, 2011
- Advances in translational bioinformatics: computational approaches for the hunting of disease genesBriefings in Bioinformatics, 2009
- Predicting new molecular targets for known drugsNature, 2009
- Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug UsesClinical Pharmacology & Therapeutics, 2009
- Genome-wide association studies: a new window into immune-mediated diseasesNature Reviews Immunology, 2008
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004